Related Experiment Video
Updated: Apr 11, 2026

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
23.3K
[Non-invasive brain stimulation for Parkinson's disease]
Revue Medicale Suisse
|June 12, 2015
Summary
Parkinson's disease presents challenges with refractory symptoms. Non-invasive brain stimulation, like transcranial direct current stimulation (tDCS), shows promise for treating debilitating symptoms such as freezing of gait.
Area of Science:
- Neurology
- Neuroscience
- Biomedical Engineering
Context:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder with significant socio-economic impact, particularly in aging populations.
- Advanced PD often involves symptoms that are resistant to standard pharmacological and surgical treatments.
- Deep brain stimulation (DBS) success highlights the potential of neuromodulation for PD management.
Purpose:
- To explore non-invasive brain stimulation (NIBS) as a therapeutic alternative for Parkinson's disease patients.
- To investigate the efficacy of transcranial direct current stimulation (tDCS) for managing refractory symptoms in PD.
- To address the therapeutic gap for patients ineligible for surgery or with treatment-resistant conditions.
Summary:
- Non-invasive brain stimulation (NIBS) offers a potential alternative to conventional therapies for Parkinson's disease (PD).
- Transcranial direct current stimulation (tDCS) is being investigated as a method to improve freezing of gait, a major cause of disability in PD.
- Ongoing therapeutic studies at the CHUV Department of Neurology are evaluating tDCS for PD symptom management.
Impact:
- NIBS, including tDCS, could provide new treatment options for Parkinson's disease patients with refractory symptoms.
- Improved management of freezing of gait may reduce falls and enhance the quality of life for individuals with PD.
- This research contributes to the development of accessible and potentially safer neuromodulation strategies for neurodegenerative diseases.
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Brain Imaging
968
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
968

